Zhu Yuling: Male, Han nationality, born in 1966, graduated from Tongji University with a bachelor's degree in clinical medicine. He has been engaged in the management of health medicine industry for a long time, has a profound background in the pharmaceutical industry, is proficient in the production, sales and distribution of pharmaceutical enterprises, and is familiar with the management of large pharmaceutical state-owned enterprises and pharmaceutical listed companies. 1990- 1994, an orthopedic surgeon in the General Hospital of Beijing Military Region, is familiar with orthopedic trauma first aid and other medical work. 1995-2003, manager of new drug branch of Shanghai Pharmaceutical Co., Ltd., familiar with the distribution of new drugs and generic drugs at home and abroad, assisting large multinational pharmaceutical companies such as Pfizer, Merck, Squibb, Sangong and Japan First Pharmaceutical to list new drugs and circulate them throughout the country. During his tenure, New Drug Branch became the largest distributor of imported drugs and pharmaceutical companies in China. In 2003-2004, he served as the chairman of Shanghai Huayin Pharmaceutical Co., Ltd., responsible for managing the drug marketing in more than 30 offices of Shanghai Pharmaceutical Co., Ltd., and in 2004-2005, he served as the deputy general manager of Shanghai Leiyunshang Pharmaceutical Sales Company, responsible for managing the drug marketing in more than 20 offices of Leiyunshang Pharmaceutical Company nationwide, which made the market of main products such as Zhenju Jiangya Tablet and Danshen Tablet grow rapidly. 2005.10-2018.1The general manager of Shanghai Kangenbei Pharmaceutical Co., Ltd. set up the Kangenbei prescription drug team in Shanghai, which became the largest sales team of domestic listed companies within ten years, and the drugs such as cardiovascular system, urinary system and neuropsychiatric drugs distributed became the first in several Shanghai market segments. 2012.8-2018.1,Chairman and General Manager of Inner Mongolia Kang 'enbei Pharmaceutical Co., Ltd., presided over the enterprise integration after the merger, and constructed the national sales network of the main product "Shexiang Tongxin Dropping Pill", realizing the overall layout in the national market. After the listing of "Shexiang Tongxin Dropping Pill", more than ten clinical studies were carried out. The enterprise has obtained the provincial high-tech enterprise, and its products have obtained the title of protected varieties of traditional Chinese medicine and the certification of intellectual property management system. 20 14- Up to now, the executive director of Guizhou Kangluowei Medical Technology Development Co., Ltd. has participated in the construction of remote medical diagnosis network in Guizhou Province, built the first regional ECG diagnosis demonstration center in the province, and formulated the data interface standard of Guizhou ECG cloud platform. 20 18.3- Up to now, the chairman of Shanghai Siwei Medical Technology Co., Ltd. manages the largest remote ECG diagnosis platform in China, serving nearly 1200 medical outlets, covering Shanghai, Jiangsu, Zhejiang, Yunnan, Shandong, Sichuan and Xinjiang 15 provinces, cities and autonomous regions. 20 18. 1- Up to now, he is a partner/general manager of Hongsheng Equity Investment Fund, focusing on venture capital in the fields of medicine, internet and high technology.